AMITA PATEL: Open Payments
NPI 1649265489 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490,266 in 490 payments from 7 companies in 2025. Trend: 2023 $413,228 · 2024 $503,651 · 2025 $490,266
Speaker / faculty: $370,743Travel & lodging: $54,514Consulting: $50,236Food & beverage: $7,520Honoraria: $7,088Education: $165
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 126 | $138,007 |
| Neurocrine BioSciences, Inc. | 113 | $134,103 |
| Otsuka America Pharmaceutical, Inc. | 154 | $121,910 |
| E.R. Squibb & Sons, L.L.C. | 68 | $63,597 |
| ACADIA Pharmaceuticals Inc | 14 | $20,179 |
| Axsome Therapeutics, Inc. | 6 | $8,295 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $4,175 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, COBENFY, UZEDY, NUPLAZID, Auvelity.
Industry payments across OH — which companies pay providers there.
